デフォルト表紙
市場調査レポート
商品コード
1007157

創傷ケア用生物製剤市場:世界の業界動向、シェア、規模、成長、機会および予測(2021~2026年)

Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
創傷ケア用生物製剤市場:世界の業界動向、シェア、規模、成長、機会および予測(2021~2026年)
出版日: 2021年05月20日
発行: IMARC Services Private Limited
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創傷ケア用生物製剤の市場規模は、2015年から2020年の間に力強い成長を示しました。創傷ケア用生物製剤は、感染症の制御および治癒に使用される天然資源から抽出または半合成された薬剤を指します。創傷治癒は、炎症、線維組織の蓄積、コラーゲンの沈着、上皮細胞層の形成、およびその他の破壊を含む複雑なプロセスです。生物学的創傷治癒治療は、活性な生物学的因子によって自然な修復メカニズムを回復する能力を持っています。たとえば、抗菌、抗炎症、または抗酸化特性を持つ植物由来の活性生体分子は、創傷治癒プロセスを進める上で効果的であることが証明されています。創傷治癒の分野で行われた最近の技術進歩には、代用皮膚、生体膜、足場、流体伝導性包帯、生物製剤などがあります。

慢性皮膚創傷は、火傷、皮膚癌、感染症、外傷、または糖尿病などの基礎疾患が原因で発生する可能性があります。高齢者人口の増加とともにこれらの病気の蔓延が増加しているため、創傷治癒を促進し、迅速な回復を促進できる治療法の需要が高まっています。これに加えて、患者の間で創傷ケア用生物製剤の利点についての認識を高めるために、世界中の政府によっていくつかのイニシアチブが行われています。また、製造業者は、それらをより入手しやすくするために、次世代の費用対効果の高い高品質の生物製剤も開発しています。さらに、多くの調査センターやヘルスケアセンターが、創傷ケア治療を近代化し、創傷治癒のための革新的な薬剤を開発するためのパートナーシップを締結しています。たとえば、研究者は抗菌化合物を創傷被覆材自体に組み込むことに焦点を当てています。これらの材料は、ヒドロゲルやフォームなどの従来の創傷被覆材と、ベタイン、銀、キチン、またはポリヘキサメチレンビグアニドなどの抗菌性化合物を組み合わせています。2021年から2026年の間に世界の創傷ケア用生物製剤市場は約8%のCAGRで成長すると予測されています。

当レポートでは、創傷ケア用生物製剤市場について調査し、市場の概要とともに、製品別、創傷タイプ別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の創傷ケア用生物製剤市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 製品別の市場セグメンテーション
  • 創傷タイプ別の市場セグメンテーション
  • 用途別の市場セグメンテーション
  • エンドユーザー別の市場セグメンテーション
  • 地域別の市場セグメンテーション

第6章 市場セグメンテーション、製品別

  • 生物学的皮膚代替品
  • 外用剤

第7章 市場セグメンテーション、創傷タイプ別

  • 潰瘍
  • 外科的および外傷性創傷
  • 熱傷

第8章 市場セグメンテーション、用途別

  • 急性創傷
  • 慢性創傷
  • 外科的創傷

第9章 市場セグメンテーション、エンドユーザー別

  • 病院
  • ASC
  • 熱傷センターと創傷クリニック

第10章 市場セグメンテーション、地域別

  • アジア太平洋
  • 欧州
  • 北米
  • 中東とアフリカ
  • ラテンアメリカ

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • キープレーヤー
  • キープレーヤーのプロファイル
    • Smith & Nephew
    • Molnlycke Health Care
    • Integra lifesciences
    • Osiris Therapeutics
    • Avita Medical
    • ConvaTec Group
    • Cytori Therapeutics
    • Mylan
    • Johnson & Johnson
    • Leap Therapeutics
    • Nuo Therapeutics
    • Mallinckrodt
    • Wright Medical
    • Mimedx Group
    • Solsys Medical
図表

List of Figures

  • Figure 1: Global: Wound Care Biologics Market: Major Drivers and Challenges
  • Figure 2: Global: Wound Care Biologics Market: Sales Value (in Billion US$), 2015 - 2020
  • Figure 3: Global: Wound Care Biologics Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Wound Care Biologics Market: Breakup by Wound Type (in %), 2020
  • Figure 5: Global: Wound Care Biologics Market: Breakup by Application (in %), 2020
  • Figure 6: Global: Wound Care Biologics Market: Breakup by End-User (in %), 2020
  • Figure 7: Global: Wound Care Biologics Market: Breakup by Region (in %), 2020
  • Figure 8: Global: Wound Care Biologics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 9: Global: Wound Care Biologics Industry: SWOT Analysis
  • Figure 10: Global: Wound Care Biologics Industry: Value Chain Analysis
  • Figure 11: Global: Wound Care Biologics Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Wound Care Biologics (Biologic Skin Substitutes) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Wound Care Biologics (Biologic Skin Substitutes) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Wound Care Biologics (Topical Agents) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Wound Care Biologics (Topical Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Wound Care Biologics (Ulcers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Wound Care Biologics (Ulcers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Wound Care Biologics (Surgical and Traumatic Wounds) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Wound Care Biologics (Burns) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Wound Care Biologics (Burns) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Wound Care Biologics (Acute Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Wound Care Biologics (Acute Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Wound Care Biologics (Chronic Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Wound Care Biologics (Chronic Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Wound Care Biologics (Surgical Wound) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Wound Care Biologics (Surgical Wound) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Wound Care Biologics (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Wound Care Biologics (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Wound Care Biologics (ASCs) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Wound Care Biologics (ASCs) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Wound Care Biologics (Burn Centres and Wound Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Asia Pacific: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Asia Pacific: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: North America: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: North America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Europe: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Europe: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Middle East and Africa: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Middle East and Africa: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Latin America: Wound Care Biologics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Latin America: Wound Care Biologics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Wound Care Biologics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Wound Care Biologics Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Wound Care Biologics Market Forecast: Breakup by Wound Type (in Million US$), 2021-2026
  • Table 4: Global: Wound Care Biologics Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 5: Global: Wound Care Biologics Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 6: Global: Wound Care Biologics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 7: Global: Wound Care Biologics Market Structure
  • Table 8: Global: Wound Care Biologics Market: Key Players
目次
Product Code: SR1020C243_Report

The global wound care biologics market exhibited strong growth during 2015-2020. Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.

Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide. Looking forward, IMARC Group expects the global wound care biologics market to grow at a CAGR of around 8% during 2021-2026.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Product:

  • Biologic Skin Substitutes
  • Human Donor Tissue-Derived Products
  • Acellular Animal -Derived Products
  • Biosynthetic Products
  • Topical Agents

Market Breakup by Wound Type:

  • Ulcers
  • Diabetic Foot Ulcers
  • Venous Ulcers
  • Pressure Ulcers
  • Others
  • Surgical and Traumatic Wounds
  • Burns

Market Breakup by Application:

  • Acute Wound
  • Chronic Wound
  • Surgical Wound

Market Breakup by End-User:

  • Hospitals
  • ASCs
  • Burn Centres and Wound Clinics

Market Breakup by Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Molnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group, Solsys Medical, etc.

Key Questions Answered in This Report:

  • How has the global wound care biologics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global wound care biologics industry?
  • What has been the impact of COVID-19 on the global wound care biologics industry?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the wound type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the global wound care biologics industry?
  • What are the key driving factors and challenges in the global wound care biologics industry?
  • What is the structure of the global wound care biologics industry and who are the key players?
  • What is the degree of competition in the global wound care biologics industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Wound Care Biologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by Wound Type
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product

  • 6.1 Biologic Skin Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Human Donor Tissue-Derived Products
      • 6.1.2.2 Acellular Animal-Derived Products
      • 6.1.2.3 Biosynthetic Products
    • 6.1.3 Market Forecast
  • 6.2 Topical Agents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Wound Type

  • 7.1 Ulcers
    • 7.1.1 Market Trends
    • 7.1.2 Market Breakup by Type
      • 7.1.2.1 Diabetic Foot Ulcers
      • 7.1.2.2 Venous Ulcers
      • 7.1.2.3 Pressure Ulcers
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Surgical and Traumatic Wounds
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Burns
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Acute Wound
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Chronic Wound
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Surgical Wound
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 ASCs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Burn Centres and Wound Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 Asia Pacific
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 North America
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porter's Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Smith & Nephew
    • 15.3.2 Molnlycke Health Care
    • 15.3.3 Integra lifesciences
    • 15.3.4 Osiris Therapeutics
    • 15.3.5 Avita Medical
    • 15.3.6 ConvaTec Group
    • 15.3.7 Cytori Therapeutics
    • 15.3.8 Mylan
    • 15.3.9 Johnson & Johnson
    • 15.3.10 Leap Therapeutics
    • 15.3.11 Nuo Therapeutics
    • 15.3.12 Mallinckrodt
    • 15.3.13 Wright Medical
    • 15.3.14 Mimedx Group
    • 15.3.15 Solsys Medical